 CAMBRIDGE, Mass., July 25, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced it will report second quarter 2022 financial results on Monday, August 1, 2022, before the U.S. financial markets open. 